Sonia Garcia Carpintero

Dr. Sonia Garcia Carpintero

Universidad de Castilla la Mancha
+1

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
SCSonia Garcia Carpintero
Sonia Garcia Carpintero
JBJavier Dominguez Bertalo
Javier Dominguez Bertalo
CPCristina Pedrero
Cristina Pedrero
JFJavier Frontiñán-Rubio
Javier Frontiñán-Rubio
Mariano Amo-SalasMariano Amo-Salas
Mariano Amo-Salas
Francisco J. AlcainFrancisco J. Alcain
Francisco J. Alcain
Ubiquinol can protect endothelial cells from multiple mechanisms that cause endothelial damage and vascular dysfunction, thus contributing to dementia. A total of 69 participants diagnosed with mild cognitive impairment (MCI) received either 200 mg/day ubiquinol (Ub) or placebo for 1 year. Cognitive assessment of patients was performed at baseline and after 1 year of follow-up. Patients’ cerebral vasoreactivity was examined using transcranial Doppler sonography, and levels of Ub and lipopolysaccharide (LPS) in plasma samples were quantified. Cell viability and necrotic cell death were determined using the microvascular endothelial cell line bEnd3. Coenzyme Q10 (CoQ) levels increased in patients supplemented for 1 year with ubiquinol versus baseline and the placebo group, although higher levels were observed in male patients. The higher cCoQ concentration in male patients improved cerebral vasoreactivity CRV and reduced inflammation, although the effect of Ub supplementation on neurological improvement was negligible in this study. Furthermore, plasma from Ub-supplemented patients improved the viability of endothelial cells, although only in T2DM and hypertensive patients. This suggests that ubiquinol supplementation could be recommended to reach a concentration of 5 μg/mL in plasma in MCI patients as a complement to conventional treatment.

19 March 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
ELEmilio Llanos-González
Emilio Llanos-González
FSFrancisco Sancho-Bielsa
Francisco Sancho-Bielsa
JFJavier Frontiñán-Rubio
Javier Frontiñán-Rubio
YRYoana Rabanal Ruiz
Yoana Rabanal Ruiz
SCSonia Garcia Carpintero
Sonia Garcia Carpintero
Mario Durán-PradoMario Durán-Prado
Mario Durán-Prado
Despite its robust proteopathic nature, the spatiotemporal signature of disrupted protein modules in sporadic Alzheimer’s disease (AD) brains remains poorly understood. This considered oxidative stress contributes to AD progression and early intervention with coenzyme Q10 or its reduced form, ubiquinol, delays the progression of the disease. Using MALDI–MSI and functional bioinformatic analysis, we have developed a protocol to express how deregulated protein modules arise from hippocampus and cortex in the AD mice model 3xTG-AD in an age-dependent manner. This strategy allowed us to identify which modules can be efficiently restored to a non-pathological condition by early intervention with ubiquinol. Indeed, an early deregulation of proteostasis-related protein modules, oxidative stress and metabolism has been observed in the hippocampus of 6-month mice (early AD) and the mirrored in cortical regions of 12-month mice (middle/late AD). This observation has been validated by IHC using mouse and human brain sections, suggesting that these protein modules are also affected in humans. The emergence of disrupted protein modules with AD signature can be prevented by early dietary intervention with ubiquinol in the 3xTG-AD mice model.